ATC code N05
ATC code N05 Psycholeptics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup N05 is part of the anatomical group N Nervous system.[4]
| ATC codes |
|---|
| N Nervous system |
| N01 Anesthetics |
| N02 Analgesics |
| N03 Antiepileptics |
| N04 Anti-parkinson drugs |
| N05 Psycholeptics |
| N06 Psychoanaleptics |
| N07 Other nervous system drugs |
| ATCvet only |
| QN51 Products for animal euthanasia |
|
|
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QN05.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
N05A Antipsychotics
N05AA Phenothiazines with aliphatic side-chain
- N05AA01 Chlorpromazine
- N05AA02 Levomepromazine
- N05AA03 Promazine
- N05AA04 Acepromazine
- N05AA05 Triflupromazine
- N05AA06 Cyamemazine
- N05AA07 Chlorproethazine
N05AB Phenothiazines with piperazine structure
- N05AB01 Dixyrazine
- N05AB02 Fluphenazine
- N05AB03 Perphenazine
- N05AB04 Prochlorperazine
- N05AB05 Thiopropazate
- N05AB06 Trifluoperazine
- N05AB07 Acetophenazine
- N05AB08 Thioproperazine
- N05AB09 Butaperazine
- N05AB10 Perazine
N05AC Phenothiazines with piperidine structure
- N05AC01 Periciazine
- N05AC02 Thioridazine
- N05AC03 Mesoridazine
- N05AC04 Pipotiazine
N05AD Butyrophenone derivatives
- N05AD01 Haloperidol
- N05AD02 Trifluperidol
- N05AD03 Melperone
- N05AD04 Moperone
- N05AD05 Pipamperone
- N05AD06 Bromperidol
- N05AD07 Benperidol
- N05AD08 Droperidol
- N05AD09 Fluanisone
- N05AD10 Lumateperone
- QN05AD90 Azaperone
N05AE Indole derivatives
- N05AE01 Oxypertine
- N05AE02 Molindone
- N05AE03 Sertindole
- N05AE04 Ziprasidone
- N05AE05 Lurasidone
N05AF Thioxanthene derivatives
- N05AF01 Flupentixol
- N05AF02 Clopenthixol
- N05AF03 Chlorprothixene
- N05AF04 Thiothixene
- N05AF05 Zuclopenthixol
N05AG Diphenylbutylpiperidine derivatives
- N05AG01 Fluspirilene
- N05AG02 Pimozide
- N05AG03 Penfluridol
N05AH Diazepines, oxazepines, thiazepines and oxepines
- N05AH01 Loxapine
- N05AH02 Clozapine
- N05AH03 Olanzapine
- N05AH04 Quetiapine
- N05AH05 Asenapine
- N05AH06 Clotiapine
C07FX Beta blocking agents, other combinations
N05AL Benzamides
- N05AL01 Sulpiride
- N05AL02 Sultopride
- N05AL03 Tiapride
- N05AL04 Remoxipride
- N05AL05 Amisulpride
- N05AL06 Veralipride
- N05AL07 Levosulpiride
N05AN Lithium
- N05AN01 Lithium
N05AX Other antipsychotics
- N05AX07 Prothipendyl
- N05AX08 Risperidone
- N05AX10 Mosapramine
- N05AX11 Zotepine
- N05AX12 Aripiprazole
- N05AX13 Paliperidone
- N05AX14 Iloperidone
- N05AX15 Cariprazine
- N05AX16 Brexpiprazole
- N05AX17 Pimavanserin
- QN05AX90 Amperozide
N05B Anxiolytics
N05BA Benzodiazepine derivatives
- N05BA01 Diazepam
- N05BA02 Chlordiazepoxide
- N05BA03 Medazepam
- N05BA04 Oxazepam
- N05BA05 Potassium clorazepate
- N05BA06 Lorazepam
- N05BA07 Adinazolam
- N05BA08 Bromazepam
- N05BA09 Clobazam
- N05BA10 Ketazolam
- N05BA11 Prazepam
- N05BA12 Alprazolam
- N05BA13 Halazepam
- N05BA14 Pinazepam
- N05BA15 Camazepam
- N05BA16 Nordazepam
- N05BA17 Fludiazepam
- N05BA18 Ethyl loflazepate
- N05BA19 Etizolam
- N05BA21 Clotiazepam
- N05BA22 Cloxazolam
- N05BA23 Tofisopam
- N05BA24 Bentazepam
- N05BA25 Mexazolam
- N05BA56 Lorazepam, combinations
N05BB Diphenylmethane derivatives
- N05BB01 Hydroxyzine
- N05BB02 Captodiame
- N05BB51 Hydroxyzine, combinations
N05BC Carbamates
- N05BC01 Meprobamate
- N05BC03 Emylcamate
- N05BC04 Mebutamate
- N05BC51 Meprobamate, combinations
N05BD Dibenzo-bicyclo-octadiene derivatives
- N05BD01 Benzoctamine
N05BE Azaspirodecanedione derivatives
- N05BE01 Buspirone
N05BX Other anxiolytics
- N05BX01 Mephenoxalone
- N05BX02 Gedocarnil
- N05BX03 Etifoxine
- N05BX04 Fabomotizole
- N05BX05 Lavandulae aetheroleum
N05C Hypnotics and sedatives
N05CA Barbiturates, plain
- N05CA01 Pentobarbital
- N05CA02 Amobarbital
- N05CA03 Butobarbital
- N05CA04 Barbital
- N05CA05 Aprobarbital
- N05CA06 Secobarbital
- N05CA07 Talbutal
- N05CA08 Vinylbital
- N05CA09 Vinbarbital
- N05CA10 Cyclobarbital
- N05CA11 Heptabarbital
- N05CA12 Reposal
- N05CA15 Methohexital
- N05CA16 Hexobarbital
- N05CA19 Thiopental
- N05CA20 Ethallobarbital
- N05CA21 Allobarbital
- N05CA22 Proxibarbal
N05CB Barbiturates, combinations
- N05CB01 Combinations of barbiturates
- N05CB02 Barbiturates in combination with other drugs
N05CC Aldehydes and derivatives
- N05CC01 Chloral hydrate
- N05CC02 Chloralodol
- N05CC03 Acetylglycinamide chloral hydrate
- N05CC04 Dichloralphenazone
- N05CC05 Paraldehyde
N05CD Benzodiazepine derivatives
- N05CD01 Flurazepam
- N05CD02 Nitrazepam
- N05CD03 Flunitrazepam
- N05CD04 Estazolam
- N05CD05 Triazolam
- N05CD06 Lormetazepam
- N05CD07 Temazepam
- N05CD08 Midazolam
- N05CD09 Brotizolam
- N05CD10 Quazepam
- N05CD11 Loprazolam
- N05CD12 Doxefazepam
- N05CD13 Cinolazepam
- N05CD14 Remimazolam
- N05CD15 Nimetazepam
- QN05CD90 Climazolam
N05CE Piperidinedione derivatives
- N05CE01 Glutethimide
- N05CE02 Methyprylon
- N05CE03 Pyrithyldione
N05CF Benzodiazepine related drugs
- N05CF01 Zopiclone
- N05CF02 Zolpidem
- N05CF03 Zaleplon
- N05CF04 Eszopiclone
N05CH Melatonin receptor agonists
- N05CH01 Melatonin
- N05CH02 Ramelteon
- N05CH03 Tasimelteon
N05CM Other hypnotics and sedatives
- N05CM01 Methaqualone
- N05CM02 Clomethiazole
- N05CM03 Bromisoval
- N05CM04 Carbromal
- N05CM05 Scopolamine
- N05CM06 Propiomazine
- N05CM07 Triclofos
- N05CM08 Ethchlorvynol
- N05CM09 Valerianae radix
- N05CM10 Hexapropymate
- N05CM11 Bromides
- N05CM12 Apronal
- N05CM13 Valnoctamide
- N05CM15 Methylpentynol
- N05CM16 Niaprazine
- N05CM18 Dexmedetomidine
- N05CM19 Suvorexant
- N05CM21 Lemborexant
- QN05CM90 Detomidine
- QN05CM91 Medetomidine
- QN05CM92 Xylazine
- QN05CM93 Romifidine
- QN05CM94 Metomidate
- QN05CM96 Tasipimidine
- QN05CM99 Combinations
N05CX Hypnotics and sedatives in combination, excluding barbiturates
- N05CX01 Meprobamate, combinations
- N05CX02 Methaqualone, combinations
- N05CX03 Methylpentynol, combinations
- N05CX04 Clomethiazole, combinations
- N05CX05 Emepronium, combinations
- N05CX06 Dipiperonylaminoethanol, combinations
References
- "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- "ATC/DDD Index 2022: code N05". WHO Collaborating Centre for Drug Statistics Methodology.
- "ATCvet Index 2022: code QN05". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.